IGF-1 DES Vials
|Molar Mass||1546.9 g/mol|
IGF-1 DES Vials represent a cutting-edge research product designed for scientific investigations. This product is formulated with Insulin-Like Growth Factor 1 (IGF-1) DES, a truncated variant of IGF-1 known for its enhanced potency. It is imperative to emphasize that IGF-1 DES Vials are strictly intended for research purposes and should not be used or considered for human consumption.
The product includes IGF-1 DES, a modified version of IGF-1 with heightened bioactivity. It is specifically formulated for accuracy and consistency in research applications, and its production is subject to rigorous quality control measures to ensure reliability.
IGF-1 DES Vials find applications in various scientific investigations, particularly in studies related to cellular growth, differentiation, and metabolism.
IGF-1 DES and Neurological Disorders
Research studies suggest that IGF-1 DES may play a role in neuroprotection and neuroregeneration. Studies have shown its potential in promoting neuronal survival and function, making it a valuable subject for research into neurological disorders such as Alzheimer’s and Parkinson’s disease.
IGF-1 DES and Immune Function
IGF-1 DES has been investigated for its impact on immune function. Preliminary studies indicate its potential to modulate immune responses, which could be crucial in understanding autoimmune disorders and developing therapeutic interventions.
IGF-1 DES and Cancer
Emerging research indicates that IGF-1 DES may influence cell proliferation and apoptosis, making it a subject of interest in cancer research. Preliminary studies suggest a potential role in inhibiting the growth of certain cancer cells, providing a foundation for further exploration.
IGF-1 DES Vials are a valuable asset in scientific research, offering a controlled and consistent source of IGF-1 DES for investigations into diverse areas such as neurological disorders, immune function, and cancer. It is crucial to emphasize that these vials are intended exclusively for research purposes and should not be used for human consumption. Researchers are encouraged to explore the potential benefits of IGF-1 DES in a controlled laboratory setting to contribute to the advancement of knowledge in these critical fields.
- Canitano R. New experimental treatments for core social domain in autism spectrum disorders. Front Pediatr. 2014 Jun 20;2:61. doi: 10.3389/fped.2014.00061. PMID: 24999471; PMCID: PMC4064155. [Read More]
- Zhao X, McBride BW, Trouten-Radford LM, Burton JH. Effects of insulin-like growth factor-I and its analogues on bovine hydrogen peroxide release by neutrophils and blastogenesis by mononuclear cells. J Endocrinol. 1993 Nov;139(2):259-65. doi: 10.1677/joe.0.1390259. PMID: 7508487. [Read More]
- Remacle-Bonnet M, Garrouste F, el Atiq F, Roccabianca M, Marvaldi J, Pommier G. des-(1-3)-IGF-I, an insulin-like growth factor analog used to mimic a potential IGF-II autocrine loop, promotes the differentiation of human colon-carcinoma cells. Int J Cancer. 1992 Dec 2;52(6):910-7. doi: 10.1002/ijc.2910520614. PMID: 1281142. [Read More]